D-0712-2026 Class II Ongoing

Recalled by Ascend Laboratories, LLC — Bedminster, NJ

FDA drug recall D-0712-2026 was initiated by Ascend Laboratories, LLC on Jul 8, 2026 and is designated Class II. Reason for recall: Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications The recall status is ongoing. Affected quantity: 6,192 bottles.

Recall details

Product Type
Drugs
Report Date
Jul 29, 2026
Initiation Date
Jul 8, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
6,192 bottles

Product description

Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA; Distributed by: Ascend Laboratories, LLC., Parsnippany, NJ 07054. NDC: 67877-500-30

Reason for recall

Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications

Distribution pattern

Nationwide in the USA

Code information

Lot 25121311, expiry 3/31/2028

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0712-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0712-2026. Report a data issue: hello@regdatalab.com.